Santen Pharm CO ADR (SNPHY)

12.01
+0.02 (0.13%)
OP· Last Trade: May 20th, 12:42 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023investorplace.com
Santen Pharmaceutical just reported results for the fourth quarter of 2023.
Via InvestorPlace · May 17, 2024
Current Analysis: Santen Pharmaceuticaltalkmarkets.com
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. Over the past year, Santen's share price rose about 32% from $7.60 to $10.01 as of Thursday’s market close
Via Talk Markets · February 15, 2024